Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Pharmacotherapy Aimed at Neuroplasticity in Autism
NCT00166621Phase 2Completed
- Start
- Mar 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of buspirone in Autism Spectrum Disorder (ASD) (2 arms). Primary endpoints: Safety and Adverse Events, Population Pharmacokinetics and 2 more. Started Mar 2004; status: completed.
02
Drugs
buspirone
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT00166621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00166621.